Justice for Victims of Fraud Act of 2017

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1414 - Camerons Law.

Client expense: $90,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions, and additional variations of the bill including: H.R. 7328 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018) and H.R. 6378 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018). H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018); amends current law to ensure the safety of cosmetics and personal care products. H.R. 919 (Blitz Gas Can bill). H.R. 3850 (Made in America Act of 2017); directs the FTC to establish labels that may be used as a voluntary means of indicating to consumers the extent to which products are of US origin; more specifically about the FTC enforcement authority. General issues pertaining to Asbestos Bankruptcy Trusts. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation. General lobbying with regard to asbestos in talc and talc generally. General lobbying with regard to nursing home arbitration. General lobbying with regard to issues relating to PFOA.

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. H.R. 6903 (Safe Cosmetics and Personal Care Products Act of 2018); amends current law to ensure the safety of cosmetics and personal care products. H.R. 919 (Blitz Gas Can bill). General issues pertaining to Asbestos Bankruptcy Trusts. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. S. 1112, (Maternal Health Accountability Act of 2017); retricts the use of information reviewed by the maternal mortality review committee. Infomration is considered confidential and not subject to dioscvery at a civil trial. S. 2852 (Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018); regarding immunity provisions. H.R. 6022/ S. 3019 (Accurate Labels Act); regarding the broad preemption of state and local labeling laws for consumer products. Cosmetic Regulation and Safety and realted preemption issues in Murray Alexander draft bill. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities S. 2564, (PROTECT Asbestos Victims Act of 2018); restricts claims against asbestos trusts and provides for criminal penalties for fraudulent claims. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues. General lobbying with regard to liability issues related to regulation of cosmetics products. General lobbying with regard to TSCA implementation.

H.R. 985 - Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act - SUPPORT H.R. 720 / S. 237 - Lawsuit Abuse Reduction Act (LARA) - SUPPORT H.R. 725 - Innocent Party Protection Act (formally Fraudulent Joinder Prevention Act) - SUPPORT H.R. 1215 - Protecting Access to Care Act - SUPPORT H.R. 1876 - Good Samaritan Health Professionals Act - SUPPORT H.R. 732 / H.R. 522 / S. 333 - Stop Settlement Slush Funds Act - SUPPORT H.R. 1033 / S. 378 - Open Book on Equal Access to Justice Act - SUPPORT H.R. 469 / S. 119 - Congressional Article I Powers Strengthening Act (formally called Sunshine for Regulatory Decrees and Settlements Act) - SUPPORT H.R. 4570 / H.R. 4734 / S. 2203 - Ending Forced Arbitration of Sexual Harassment Act - OPPOSE H.R. 1396 / S. 550 - Restoring Statutory Rights and Interests of the States Act - OPPOSE S. 542 - Safety Over Arbitration Act - OPPOSE H.R. 832 - Arbitration Transparency Act - OPPOSE H.R. 1414 / S. 552 - Justice for Victims of Fraud Act - OPPOSE H.R. 2631 / S. 646 - Justice for Service Members and Veterans Act - OPPOSE S. 647 - Mandatory Arbitration Transparency Act - OPPOSE H.R. 1374 / S. 537 - Arbitration Fairness Act - OPPOSE

Client expense: $10,000 · Firm income: Not reported

All legislation, executive orders or agency actions pertaining to the Consumer Financial Protection Bureau, including to restrict its authorities, change its structure to a commission or modify its independent funding and all proposals to implement the Congressional Review Act to rescind CFPB rules, including the prepaid card rule of October 2016 and the arbitration rule of July 2017; comment on all rules proposed by the CFPB, including its high-cost (payday) and arbitration draft rules. Comment on all Executive Orders and Requests for Information pertaining to changing or limiting the structure of US Financial Regulation system. All agency proposed rules, requests for Information or guidances concerning "fintech" firms and their chartering. Oppose all appropriations riders to subject independent agencies to restrictive, duplicative regulatory cost-benefit analysis and OMB/OIRA oversight. Bills include S2155, The Economic Growth, Regulatory Relief, and Consumer Protection Act, HR3746, The Business of Insurance Regulatory Reform Act of 2017; HR2396, The Privacy Notification Technical Clarification Act; HR435, The Credit Access and Inclusion Act of 2017; HR2706, The Financial Institution Customer Protection Act of 2017; HR10 (Financial Choice Act)/S370 (Repeal CFPB Act), S365 (Change Funding of CFPB), S387 (Consumer Financial Protection Bureau Accountability Act of 2017), S105 (Consumer Financial Protection Board Act of 2017), S626 (CFPB-IG Act of 2017), S552/HR1414 (Justice for Victims of Fraud Act of 2017), HR50 (Unfunded Mandates Information and Transparency Act of 2017), HR1116/S366 (TAILOR Act of 2017), HR1018 (CFPB Constitutional Reform Act of 2017) and SJR19/HJR73/HJR62 (To repeal CFPB Prepaid rule) and HJR 111/SJR47 to repeal CFPB arbitration rule. HR2133 (CLEARR Act of 2017 to weaken civil rights lending laws). HR5 (Regulatory Accountability Act) and similar regulatory/Administrative Procedures Act/benefit-cost analysis bills and riders. S1816, S1810, HR3878 and other bills to enact free credit freezes. S1786 (Secure Act)/HR3755 (Comprehensive Credit Reform Reporting Act and S1819/HR3783 (Equal Credit for All Acts) to amend the Fair Credit Reporting Act. HR3606 (Overdraft Protection Act). cOppose HR 3796 (Anti-Pyramid Scheme Promotion Act) and any riders to do same. HR3280 (Financial Services and General Government Appropriations Act) and any riders incorporated to weaken CFPB or Dodd-Frank Act generally. Support FHFA Preferred Language efforts.

All legislation, executive orders or agency actions pertaining to the Consumer Financial Protection Bureau, including to restrict its authorities, change its structure to a commission or modify its independent funding and all proposals to implement the Congressional Review Act to rescind CFPB rules, including the prepaid card rule of October 2016 and the arbitration rule of July 2017; comment on all rules proposed by the CFPB, including its high-cost (payday) and arbitration draft rules. Comment on all Executive Orders and Requests for Information pertaining to changing or limiting the structure of US Financial Regulation system. All agency proposed rules, requests for Information or guidances concerning "fintech" firms and their chartering. Oppose all appropriations riders to subject independent agencies to restrictive, duplicative regulatory cost-benefit analysis and OMB/OIRA oversight. Bills include S2155, The Economic Growth, Regulatory Relief, and Consumer Protection Act, HR3746, The Business of Insurance Regulatory Reform Act of 2017; HR2396, The Privacy Notification Technical Clarification Act; HR435, The Credit Access and Inclusion Act of 2017; HR2706, The Financial Institution Customer Protection Act of 2017; HR10 (Financial Choice Act)/S370 (Repeal CFPB Act), S365 (Change Funding of CFPB), S387 (Consumer Financial Protection Bureau Accountability Act of 2017), S105 (Consumer Financial Protection Board Act of 2017), S626 (CFPB-IG Act of 2017), S552/HR1414 (Justice for Victims of Fraud Act of 2017), HR50 (Unfunded Mandates Information and Transparency Act of 2017), HR1116/S366 (TAILOR Act of 2017), HR1018 (CFPB Constitutional Reform Act of 2017) and SJR19/HJR73/HJR62 (To repeal CFPB Prepaid rule) and HJR 111/SJR47 to repeal CFPB arbitration rule. HR2133 (CLEARR Act of 2017 to weaken civil rights lending laws). HR5 (Regulatory Accountability Act) and similar regulatory/Administrative Procedures Act/benefit-cost analysis bills and riders. S1816, S1810, HR3878 and other bills to enact free credit freezes. S1786 (Secure Act)/HR3755 (Comprehensive Credit Reform Reporting Act and S1819/HR3783 (Equal Credit for All Acts) to amend the Fair Credit Reporting Act. HR3606 (Overdraft Protection Act). cOppose HR 3796 (Anti-Pyramid Scheme Promotion Act) and any riders to do same. HR3280 (Financial Services and General Government Appropriations Act) and any riders incorporated to weaken CFPB or Dodd-Frank Act generally. Support FHFA Preferred Language efforts.

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. S. 2203/H.R. 4734/H.R. 4570 (Ending Forced Arbitration of Sexual Harassment Act of 2017); prohibits a pre-dispute arbitration agreement from being valid or enforceable if it requires arbitration of a sex discrimination dispute. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues.

All legislation, executive orders or agency actions pertaining to the Consumer Financial Protection Bureau, including to restrict its authorities, change its structure to a commission or modify its independent funding and all proposals to implement the Congressional Review Act to rescind CFPB rules, including the prepaid card rule of October 2016 and the arbitration rule of July 2017; comment on all rules proposed by the CFPB, including its high-cost (payday) and arbitration draft rules. Comment on all Executive Orders and Requests for Information pertaining to changing or limiting the structure of US Financial Regulation system. All agency proposed rules, requests for Information or guidances concerning ""fintech"" firms and their chartering. Oppose all appropriations riders to subject independent agencies to restrictive, duplicative regulatory cost-benefit analysis and OMB/OIRA oversight. Bills include HR10 (Financial Choice Act)/S370 (Repeal CFPB Act), S365 (Change Funding of CFPB), S387 (Consumer Financial Protection Bureau Accountability Act of 2017), S105 (Consumer Financial Protection Board Act of 2017), S626 (CFPB-IG Act of 2017), S552/HR1414 (Justice for Victims of Fraud Act of 2017), HR50 (Unfunded Mandates Information and Transparency Act of 2017), HR1116/S366 (TAILOR Act of 2017), HR1018 (CFPB Constitutional Reform Act of 2017) and SJR19/HJR73/HJR62 (To repeal CFPB Prepaid rule) and HJR 111/SJR47 to repeal CFPB arbitration rule. HR2133 (CLEARR Act of 2017 to weaken civil rights lending laws). HR5 (Regulatory Accountability Act) and similar regulatory/Administrative Procedures Act/benefit-cost analysis bills and riders. S1816, S1810, HR3878 and other bills to enact free credit freezes. S1786 (Secure Act)/HR3755 (Comprehensive Credit Reform Reporting Act and S1819/HR3783 (Equal Credit for All Acts) to amend the Fair Credit Reporting Act. HR3606 (Overdraft Protection Act). cOppose HR 3796 (Anti-Pyramid Scheme Promotion Act) and any riders to do same. HR3280 (Financial Services and General Government Appropriations Act) and any riders incorporated to weaken CFPB or Dodd-Frank Act generally. OCC - Urge agency not to establish special national bank charter for finetch firms. FHFA - In response to Request for Input (RFI), urge this agency (new name ends in Agency-FHFA) to improve language access in materials.

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 646/H.R. 2631 (Justice for Servicemembers and Veterans Act); amends title 38, United States Code, to improve the enforcement of employment and reemployment rights of members of the uniformed services, to amend the Servicemembers Civil Relief Act to improve the protection of members of the uniformed services. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. H.R. 3857 (PASS Act of 2017); amend the Securities Exchange Act of 1934 to lower standards of conduct for brokers and dealers that are in the best interest of their retail customers. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. General lobbying with regard to asbestos exposure and related health and environmental issues.

All legislation, executive orders or agency actions pertaining to the Consumer Financial Protection Bureau, including to restrict its authorities, change its structure to a commission or modify its independent funding and all proposals to implement the Congressional Review Act to rescind CFPB rules, including the prepaid card rule of October 2016; comment on all rules proposed by the CFPB, including its high-cost (payday) and arbitration draft rules. Comment on all Executive Orders and Requests for Information pertaining to changing or limiting the structure of US Financial Regulation system. All agency proposed rules, requests for Information or guidances concerning "fintech" firms and their chartering. Oppose all appropriations riders to subject independent agencies to restrictive, duplicative regulatory cost-benefit analysis and OMB/OIRA oversight. Bills include HR10 (Financial Choice Act)/S370 (Repeal CFPB Act), S365 (Change Funding of CFPB), S387 (Consumer Financial Protection Bureau Accountability Act of 2017), S105 (Consumer Financial Protection Board Act of 2017), S626 (CFPB-IG Act of 2017), S552/HR1414 (Justice for Victims of Fraud Act of 2017), HR50 (Unfunded Mandates Information and Transparency Act of 2017), HR1116/S366 (TAILOR Act of 2017), HR1018 (CFPB Constitutional Reform Act of 2017) and SJR19/HJR73/HJR62 (To repeal CFPB Prepaid rule). HR2133 (CLEARR Act of 2017 to weaken civil rights lending laws). HR5 (Regulatory Accountability Act) and similar regulatory/Administrative Procedures Act/benefit-cost analysis bills and riders.

Client expense: $10,000 · Firm income: Not reported

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos. H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. General lobbying with regard to asbestos exposure and related health and environmental issues. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. S. 1113 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. General lobbying with regard to draft legislation relating to cosmetic regulation. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending Telephone Consumer Protection Act liability. General lobbying with regard to attorney advertising issues. S. 534/H.R. 1973 (Protecting Young Victims from Sexual Abuse Act of 2017); prevents the sexual abuse of minors and amateur athletes by requiring the prompt reporting of sexual abuse to law enforcement authorities

Legislation; HR 2896, Taking Account of Institutions with Low Operation Risk Act of 2015; H.R. 766, the Financial Institution Customer Protection Act of 2015; All legislation concerning budget views or appropriations, including concerning riders on independent funding, structure and authority of CFPB (Financial Services and General Government Appropriations (HR5485/S2663); riders on transportation safety and airline fee disclosure. All legislation concerning amendments to DoddFrank Wall Street Reform and Consumer Protection Act, including authority of agencies to enforce laws to protect consumers, taxpayers. H.R.4781 FDIC Accountability Act of 2016; HR 1265, Bureau Advisory Commission Transparency Act; HR 1263, Consumer Financial Protection Safety and Soundness Improvement Act of 2015; HR 1262, Consumer Right to Financial Privacy Act of 2015; HR 1264, CFPB Pay Fairness Act of 2015; HR 1261, Bureau of Consumer Financial Protection Accountability Act of 2015; HR 1413/S477, Firearms Manufacturers and Dealers Protection Act of 2015 (FDIC Operation Choke Point); H.R. 766 and S2790, the Financial Institution Customer Protection Act of 2015. HR 5510, to weaken FTC; HR 4768 Separation of Powers Restoration Act; other riders and amendments to weaken independent agency authority to enact regulations. HR4172 Full file credit reporting; HR5282 Fair Credit Reporting Act amendments. Department of Education Gainful Employment rule. including HR4768, the Separation of Powers Restoration Act; HR4612 and sections of HR4361 concerning the Midnight Rules Relief Act; S2355, the Credit Access and Inclusion Act; HR5424, the Investment Advisors Modernization Act; HR5226, the Regulatory Integrity Act; HR3468, The Review Act; HR5063, the Stop Settlement Funds Act and any similar riders proposed to Appropriations Bills such as HR5485/SB3067, Financial Services and General Government Appropriations Acts for 2017. File comments to CFPB on Docket 20160020 on forced arbitration; file comment to CFPB on announcement of Debt Collection rulemaking SBREFA process; meet with CFPB on consumer complaint database, payday lending and other matters. File comment to financial and bank regulators on status of completion of rulemaking on DoddFrank Section 956, Executive Compensation; All legislation pertaining to the Consumer Financial Protection Bureau, including to restrict its authorities, change its structure to a commission or modify its independent funding and all proposals to implement the Congressional Review Act to rescind CFPB rules, including the prepaid card rule of October 2016; comment on all rules proposed by the CFPB, including its high-cost (payday) and arbitration draft rules. Comment on all Executive Orders and Requests for Information pertaining to changing or limiting the structure of US Financial Regulation system. All agency proposed rules, requests for Information or guidances concerning "fintech" firms and their chartering. Oppose all appropriations riders to subject independent agencies to restrictive, duplicative regulatory cost-benefit analysis and OMB/OIRA oversight. Bills include HR103/S370, S365, S387, S105, S626, S552/HR1414, HR50, HR1116/S366, HR1018 and SJR19/HJR73/HJR62.

H.R. 906 (Furthering Asbestos Claims Transparency Act); amends title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos H.R. 1563 (Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2017); amends the Public Health Service Act to provide for the establishment of a mesothelioma patient registry. General lobbying with regard to asbestos exposure and related health and environmental issues. H.R. 575 (Cosmetic Modernization Amendments of 2017); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. Lobbying with specific regard to draft Personal Care Products Safety Act and legislation to regulate cosmetic products and ingredients. H.R. 832 (Arbitration Transparency Act); amends title 9 of the United States Code to require that arbitration proceedings in certain disputes involving consumer financial products and services be open to the public. S. 542 (Safety Over Arbitration Act of 2017); amends title 9, United States Code, with respect to arbitration where the claim or controversy alleges facts relevant to a hazard to public health or safety. S. 552/H.R. 1414 (Justice for Victims of Fraud Act); amends the Truth in Lending Act and the Electronic Fund Transfer Act to provide justice to victims of fraud. S. 550/H.R. 1396 (Restoring Statutory Rights Act); invalidates arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution. S. 647 (Mandatory Arbitration Transparency Act); amends title 9, United States Code, with respect to arbitration. S. 537/H.R. 1374 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in employment, consumer, antitrust, or civil rights disputes. General lobbying with regard to the Education Departments borrower defenses rule. General lobbying with regard to the CMS long term care rule. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. General lobbying with regard to pesticide regulations. General lobbying with regard to amending the Telephone Consumer Protection Act.